Top compounds associated with response to LXN


Feature Type Standardized
Nominal ANOVA
mRNA nintedanib CTRPv2 pan-cancer AAC 0.11 0.005
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.006
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.006
mRNA AZ628 GDSC1000 pan-cancer AAC 0.14 0.006
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.006
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.006
mRNA AT13387 CTRPv2 pan-cancer AAC -0.13 0.007
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.09 0.008
mRNA Vorinostat gCSI pan-cancer AAC -0.14 0.009
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.096 0.009
Download CSV